ProCE Banner Activity

My Thoughts on the Care of Advanced Renal Cell Carcinoma Today

Clinical Thought

An up-to-date overview for APPs who treat advanced renal cell carcinoma, covering considerations for adjuvant therapy, treatment selection and sequencing, and managing treatment-related adverse events to optimize patient care.

Released: May 30, 2023

Share

Faculty

Mary Weinstein Dunn

Mary Weinstein Dunn, MSN

Nurse Practitioner
Department of Urology and Medicine, Division of Oncology
University of North Carolina Chapel Hill
Chapel Hill, North Carolina

Provided by

Provided by Partners for Advancing Clinical Education (PACE)

ProCE Banner

Supporters

Supported by educational grants from Exelixis, Inc., and Merck Sharp & Dohme LLC.

Exelixis, Inc.

Merck Sharp & Dohme, LLC

Disclaimer

Primary Author

Mary Weinstein Dunn, MSN

Nurse Practitioner
Department of Urology and Medicine, Division of Oncology
University of North Carolina Chapel Hill
Chapel Hill, North Carolina

Mary Weinstein Dunn, MSN, has no relevant financial relationships to disclose.